Fractal Analytics, Amagi, and Sahajanand Medical Secure Regulatory Nod to Launch IPOs

Mumbai, November 25, 2025: In recent IPO developments, three major companies have received regulatory approval to launch their initial public offerings. This means that the three companies can now move ahead with their individual IPO plans. This includes Fractal Analytics, which is an Artificial intelligence specialist, Amagi Media Labs, which is a cloud-based SaaS provider and Sahajanand Medical Technologies, which is a cardiac stent manufacturer.

Fractal Analytics IPO

The IPO of Fractal Analytics will be worth Rs 4,900 crore. This will include both a fresh issue and a substantial offer for sale (OFS). The fresh issue will total about Rs 1,279.3 crore. Whereas the OFS will total about Rs 3,620.7 crore. The offer from the sale is mainly from four investors. This includes  Quinag Bidco Ltd, which is offering shares worth Rs 1,462.6 crore, TPG Fett Holdings, which is offering Rs 1,999.6 crore, Satya Kumari Remala and Rao Venkateswara Remala, which are offering Rs 29.5 crore, and GLM Family Trust, which is offering shares worth Rs 129.0 crore.

The company will use the proceeds from the IPO to invest in its US-based subsidiary. The company also plans to repay its debts, procure laptops and a new office setup in India through the proceeds. Further, the company will also make an investment in research and development, expand its sales and marketing under Fractal Alpha, make acquisitions, and take other corporate actions.

Fractal Analytics was founded in 2000. The company delivers end-to-end artificial intelligence and data-driven decision-making solutions to global enterprises. It has some major investors such as TPG, Apax, and Gaja among its backers.

Amagi Plans IPO

Amagi Media Labs is planning an IPO comprising both a fresh issue and an Offer for Sale. The fresh issue is expected to raise about ₹1,020 crore, while the OFS will involve 3.41 crore equity shares. Headquartered in Bengaluru, the company delivers cloud-led media technology solutions to broadcasters and content owners worldwide.

Amagi aims to raise roughly ₹667 crore from the fresh issue to upgrade its technology and cloud infrastructure. The remaining proceeds will be allocated for inorganic growth, including acquisitions and general corporate purposes.

Sahajanand Medical IPO

Sahajanand Medical Technologies, founded in 2001, specialises in medical devices for Vascular Intervention and Structural Heart therapies, supported by R&D centres in India and Thailand. Its IPO will comprise only an Offer for Sale, with no fresh issue of shares. Around 2.76 crore equity shares will be offloaded by existing promoters and investors. Key selling shareholders include Shree Hari Trust, Samara Capital Markets Holding, Kotak Pre-IPO Opportunities Fund, and NHPEA Sparkle Holding BV.

Disclaimer:  At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations